(Q40210597)
Statements
1 reference
The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor AG1478 increases the formation of inactive untethered EGFR dimers. Implications for combination therapy with monoclonal antibody 806. (English)
1 reference
Hui K Gan
1 reference
Francesca Walker
1 reference
Antony W Burgess
1 reference
Angela Rigopoulos
1 reference
Andrew M Scott
1 reference
8 November 2006
1 reference
1 reference
282
1 reference
5
1 reference
2840-2850
1 reference
Identifiers
1 reference
1 reference